Differentially expressed lncRNAs in liver tissues of TX mice with hepatolenticular degeneration

Juan Zhang, Ying Ma, Daojun Xie, Bao Yuan-cheng, Wenming Yang, Han Wang, Huaizhou Jiang, Hui Han, Ting DongScientific 2021 · DOI

TL;DR

This study investigates the role of long non-coding RNAs (lncRNAs) in Wilson's Disease (WD) liver injury using a mouse model. By analyzing lncRNA and mRNA expression profiles, researchers identified key regulatory networks and pathways implicated in the disease, suggesting potential diagnostic markers and therapeutic targets.

What Problem Does This Paper Address?

Wilson's Disease (WD) is a genetic disorder characterized by impaired copper excretion, leading to copper accumulation and subsequent liver and neurological damage. While the role of genes like ATP7B is known, the intricate molecular mechanisms driving WD-associated liver injury, particularly the involvement of non-coding RNAs, remain less understood. This paper aims to bridge this knowledge gap by exploring the landscape of differentially expressed lncRNAs and their regulatory interactions with protein-coding genes in the context of WD liver pathology.

Methods

The researchers employed a multi-pronged approach:

  • RNA Sequencing (RNA-seq): Deep RNA-seq was performed on liver tissues from both a TX WD mouse model and control mice to comprehensively profile lncRNA and mRNA expression.
  • Differential Expression Analysis: Standard statistical methods were used to identify lncRNAs and mRNAs that were significantly up- or down-regulated between the WD model and control groups.
  • Gene Ontology (GO) and KEGG Pathway Enrichment Analysis: These analyses were used to infer the biological functions and signaling pathways associated with the differentially expressed genes.
  • Co-expression Network Construction: A crucial step involved constructing lncRNA-mRNA co-expression networks using Pearson's correlation coefficients to identify potential regulatory relationships. This was done using the CNC analysis and visualized with Cytoscape.
  • Real-time Quantitative PCR (RT-qPCR): This technique was used to validate the RNA-seq findings for a selected set of differentially expressed lncRNAs.

Datasets

The study utilized liver tissue samples from:

  • TX WD mouse model: A genetically modified mouse model exhibiting hepatolenticular degeneration, serving as the disease model.
  • Control mice: Healthy mice used for comparison.

The RNA-seq data generated from these samples formed the basis for the analysis. No new public benchmarks were introduced.

Key Insights and Ideas

  • LncRNAs are Abundant and Dysregulated in WD Liver Injury: The study revealed a substantial number of differentially expressed lncRNAs (2564 up-regulated, 1052 down-regulated) and mRNAs (1576 up-regulated, 297 down-regulated) in the WD mouse model, highlighting their significant involvement in the disease process.
  • Complex Regulatory Networks: The construction of lncRNA-mRNA co-expression networks unveiled intricate interactions, suggesting that lncRNAs act as key regulators orchestrating the expression of multiple protein-coding genes involved in WD pathogenesis.
  • Key Pathways Implicated: Enrichment analysis pointed towards critical biological processes and pathways, including apoptosis, drug metabolism (cytochrome P450), PPAR signaling, Notch signaling, and MAPK signaling, as being significantly affected in WD liver injury. These pathways are known to be involved in inflammation, cell death, and metabolic processes relevant to liver health.
  • Potential Biomarkers Identified: Specific lncRNAs, such as MEG3, H19, and SNHG18, were highlighted as potentially playing major roles and could serve as valuable biomarkers for WD.

Key Results

  • Differential Expression: The study identified 2564 significantly up-regulated and 1052 down-regulated lncRNAs, along with 1576 up-regulated and 297 down-regulated mRNAs.
  • Co-expression Network: A total of 62,559 lncRNA transcripts were identified, with a significant portion (50,079) expressed in both control and model groups. The co-expression network analysis revealed numerous interactions between lncRNAs and protein-coding genes.
  • Pathway Enrichment: KEGG analysis showed enrichment in pathways such as drug metabolism-cytochrome P450, PPAR signaling, Notch signaling, and MAPK signaling.
  • RT-qPCR Validation: The RNA-seq results for several key lncRNAs were successfully validated using RT-qPCR, confirming the reliability of the transcriptomic data.

Limitations and Future Work

  • Mouse Model vs. Human Disease: While the TX WD mouse model is a valuable tool, it may not perfectly recapitulate all aspects of human WD. Further validation in human samples is warranted.
  • Functional Validation: The study identified potential roles for lncRNAs and pathways, but direct functional validation of these lncRNAs in the context of WD liver injury is needed. This could involve knockdown or overexpression experiments to confirm their causal roles.
  • Mechanism Elucidation: While co-expression networks suggest regulatory relationships, the precise molecular mechanisms by which these lncRNAs exert their effects require further investigation.
  • Therapeutic Potential: The identified lncRNAs and pathways represent promising targets for therapeutic intervention, but extensive preclinical and clinical studies would be necessary to develop effective treatments.

The authors suggest that their findings provide a foundation for developing new diagnostic markers and therapeutic targets for WD, emphasizing the need for further experimental validation.

Summary updated

Abstract

Wilson's Disease (WD), an ATP7B-mutated inherited disease that affects copper transport, is characterised by liver and nervous system manifestations. Long non-coding (ln-c) RNAs are widely involved in almost all physiological and pathological processes in the body, and are associated with numerous diseases. The present study aimed to elucidate the lncRNA-mRNA regulation network in a TX WD mouse model using RNA sequencing (RNA-seq). lncRNA expression profiles were screened using RNA-seq and real-time polymerase chain reaction, and differentially expressed lncRNAs and mRNAs were identified. To analyse the biological functions and pathways for the differentially expressed mRNAs, gene ontology and pathway enrichment analyses were performed. A significantly correlated lncRNA-mRNA relationship pair was calculated by CNC analysis to construct differential lncRNA and mRNA co-expression networks. A total of 2564 significantly up-regulated and 1052 down-regulated lncRNAs, and 1576 up-regulated and 297 down-regulated mRNAs, were identified. These genes were found to be associated with key processes such as apoptosis, and KEGG analysis revealed enrichment in the drug metabolism-cytochrome P450 pathway, PPAR signalling pathway, Notch signalling pathway, and MAPK signalling pathway. The identified differential lncRNAs may be involved in the pathogenesis and development of WD liver injury.
BibTeX
@inproceedings{zhang2021differentially,
  author = {Juan Zhang and Ying Ma and Daojun Xie and Bao Yuan-cheng and Wenming Yang and Han Wang and Huaizhou Jiang and Hui Han and Ting Dong},
  title = {{Differentially expressed lncRNAs in liver tissues of TX mice with hepatolenticular degeneration}},
  booktitle = {Scientific},
  year = {2021},
  doi = {10.1038/s41598-020-80635-0},
}
Figure